EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
Crossref DOI link: https://doi.org/10.1007/s11096-018-0709-6
Published Online: 2018-08-09
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Francescon, Sara
Fornasier, Giulia
Baldo, Paolo http://orcid.org/0000-0002-5106-7120
Text and Data Mining valid from 2018-08-01
Version of Record valid from 2018-08-09
Article History
Received: 5 January 2018
Accepted: 30 July 2018
First Online: 9 August 2018